| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Concise Reviews |
a Departments of Medicine and
b Pediatric Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA;
c The Jackson Laboratory, Bar Harbor, Maine, USA
Key Words. scid mouse • Hemopoiesis • Stem cell • Differentiation • Animal model • scid repopulating cell (SRC) • Hu-SRC-SCID
Dr. Leonard D. Shultz, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
The discovery of the severe combined immunodeficiency (scid) mouse mutation has provided a tool for establishment of small animal models as hosts for the in vivo analysis of normal and malignant human pluripotent hemopoietic stem cells. Intravenous injection of irradiated scid mice with human bone marrow, cord blood, or G-CSF cytokine-mobilized peripheral blood mononuclear cells, all rich in human hemopoietic stem cell activity, results in the engraftment of a human hemopoietic system in the murine recipient. This model has been used to identify a pluripotent stem cell, termed "scid-repopulating cell" (SRC) that is more primitive than any of the hemopoietic stem cell populations identified using the currently available in vitro methodology. In this review, we describe the development and use of this model system, termed Hu-SRC-SCID, and summarize the discoveries that have resulted from the investigation of human stem cells in this model. Finally, we detail the recent extension of the original Hu-SRC-SCID model system based on the C.B-17-scid mouse as the murine host to the Hu-SRC-NOD-SCID model based on the NOD-scid mouse as the host. The engraftment of human stem cells in the Hu-SRC-NOD-SCID model is enhanced over that observed in the Hu-SRC-SCID model and results in exceptionally high levels of human hemopoietic cells in the murine recipient. Future directions to further improve the Hu-SRC-NOD-SCID model system and the potential utility of this model in the preclinical and diagnostic arenas of hematology and oncology are discussed.
This article has been cited by other articles:
|
|
 |
|
  A. Fierabracci, M. A. Puglisi, L. Giuliani, S. Mattarocci, and M. Gallinella-Muzi Identification of an adult stem/progenitor cell-like population in the human thyroid J. Endocrinol., September 1, 2008; 198(3): 471 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Niclou, C. Danzeisen, H. P. Eikesdal, H. Wiig, N. H. C. Brons, A. M. F. Poli, A. Svendsen, A. Torsvik, P. O. Enger, J. A. Terzis, et al. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions FASEB J, September 1, 2008; 22(9): 3120 - 3128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Otto, X. Chen, W. J. Martin, W. Leung, J. Knowles, M. Holladay, J. Houston, R. Handgretinger, and R. C. Barfield Selection of Stem Cells by Using Antibodies That Target Different CD34 Epitopes Yields Different Patterns of T-Cell Differentiation Stem Cells, February 1, 2007; 25(2): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.E. Gargett Uterine stem cells: What is the evidence? Hum. Reprod. Update, January 1, 2007; 13(1): 87 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ando, T. Yahata, T. Sato, H. Miyatake, H. Matsuzawa, M. Oki, H. Miyoshi, T. Tsuji, S. Kato, and T. Hotta Direct evidence for ex vivo expansion of human hematopoietic stem cells Blood, April 15, 2006; 107(8): 3371 - 3377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Legrand, K. Weijer, and H. Spits Experimental Models to Study Development and Function of the Human Immune System In Vivo J. Immunol., February 15, 2006; 176(4): 2053 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sun, H. Wei, R. Sun, W. Xiao, Y. Yang, and Z. Tian Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice Clin. Vaccine Immunol., February 1, 2006; 13(2): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. DiJoseph, M. M. Dougher, L. B. Kalyandrug, D. C. Armellino, E. R. Boghaert, P. R. Hamann, J. K. Moran, and N. K. Damle Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma Clin. Cancer Res., January 1, 2006; 12(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Macchiarini, M. G. Manz, A. K. Palucka, and L. D. Shultz Humanized mice: are we there yet? J. Exp. Med., November 21, 2005; 202(10): 1307 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K.C. Brolen, N. Heins, J. Edsbagge, and H. Semb Signals From the Embryonic Mouse Pancreas Induce Differentiation of Human Embryonic Stem Cells Into Insulin-Producing {beta}-Cell-Like Cells Diabetes, October 1, 2005; 54(10): 2867 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Cummings, N. Uchida, S. J. Tamaki, D. L. Salazar, M. Hooshmand, R. Summers, F. H. Gage, and A. J. Anderson Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice PNAS, September 27, 2005; 102(39): 14069 - 14074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Przyborski Differentiation of Human Embryonic Stem Cells After Transplantation in Immune-Deficient Mice Stem Cells, September 1, 2005; 23(9): 1242 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yoshida, F. Ishikawa, N. Kawano, K. Shimoda, S. Nagafuchi, S. Shimoda, M. Yasukawa, T. Kanemaru, H. Ishibashi, L. D. Shultz, et al. Human Cord Blood-Derived Cells Generate Insulin-Producing Cells In Vivo Stem Cells, September 1, 2005; 23(9): 1409 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ishikawa, M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice Blood, September 1, 2005; 106(5): 1565 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al. Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells J. Immunol., May 15, 2005; 174(10): 6477 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, E. Salido, Y. Zhou, S. Bhattacharyya, S. M. Yannone, E. Dunn, J. Meneses, A. J. Feeney, and M. J. Cowan Targeted Disruption of the Artemis Murine Counterpart Results in SCID and Defective V(D)J Recombination That Is Partially Corrected with Bone Marrow Transplantation J. Immunol., February 15, 2005; 174(4): 2420 - 2428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Islas-Ohlmayer, A. Padgett-Thomas, R. Domiati-Saad, M. W. Melkus, P. D. Cravens, M. d. P. Martin, G. Netto, and J. V. Garcia Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34+ Cells with Epstein-Barr Virus J. Virol., December 15, 2004; 78(24): 13891 - 13900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. DiJoseph, M. E. Goad, M. M. Dougher, E. R. Boghaert, A. Kunz, P. R. Hamann, and N. K. Damle Potent and Specific Antitumor Efficacy of CMC-544, a CD22-Targeted Immunoconjugate of Calicheamicin, against Systemically Disseminated B-Cell Lymphoma Clin. Cancer Res., December 15, 2004; 10(24): 8620 - 8629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Kolar, T. Yokota, M. I. D. Rossi, S. K. Nath, and J. D. Capra Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire Blood, November 1, 2004; 104(9): 2981 - 2987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J.-C. Piffaretti, A. Lanzavecchia, and M. G. Manz Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice Science, April 2, 2004; 304(5667): 104 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Walter-Yohrling, S. Morgenbesser, C. Rouleau, R. Bagley, M. Callahan, W. Weber, and B. A. Teicher Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells Clin. Cancer Res., March 15, 2004; 10(6): 2179 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Punzon, L. M. Criado, A. Serrano, F. Serrano, and A. Bernad Highly efficient lentiviral-mediated human cytokine transgenesis on the NOD/scid background Blood, January 15, 2004; 103(2): 580 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Horn, B. M. Thomasson, B. L. Wood, R. G. Andrews, J. C. Morris, and H.-P. Kiem Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates Blood, December 15, 2003; 102(13): 4329 - 4335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Turgeon, S. J. Banuelos, L. D. Shultz, B. L. Lyons, N. Iwakoshi, D. L. Greiner, J. P. Mordes, A. A. Rossini, and M. C. Appel Alloimmune Injury and Rejection of Human Skin Grafts on Human Peripheral Blood Lymphocyte-Reconstituted Non-Obese Diabetic Severe Combined Immunodeficient {beta}2-Microglobulin-Null Mice Experimental Biology and Medicine, October 1, 2003; 228(9): 1096 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Beider, A. Nagler, O. Wald, S. Franitza, M. Dagan-Berger, H. Wald, H. Giladi, S. Brocke, J. Hanna, O. Mandelboim, et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice Blood, September 15, 2003; 102(6): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Laufs, B. Gentner, K. Z. Nagy, A. Jauch, A. Benner, S. Naundorf, K. Kuehlcke, B. Schiedlmeier, A. D. Ho, W. J. Zeller, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells Blood, March 15, 2003; 101(6): 2191 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G R Kolar and J D Capra The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE Lupus, March 1, 2003; 12(3): 158 - 162. [Abstract] [PDF]
|
|
|
|
|
|
H. Eichler, S. Kern, C. Beck, W. Zieger, and H. Kluter Engraftment Capacity of Umbilical Cord Blood Cells Processed by Either Whole Blood Preparation or Filtration Stem Cells, March 1, 2003; 21(2): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nitsche, I. Junghahn, S. Thulke, J. Aumann, A. Radonic, I. Fichtner, and W. Siegert Interleukin-3 Promotes Proliferation and Differentiation of Human Hematopoietic Stem Cells but Reduces Their Repopulation Potential in NOD/SCID Mice Stem Cells, March 1, 2003; 21(2): 236 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Hofling, C. Vogler, M. H. Creer, and M. S. Sands Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease Blood, March 1, 2003; 101(5): 2054 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Askenasy, T. Zorina, D. L. Farkas, and I. Shalit Transplanted Hematopoietic Cells Seed in Clusters in Recipient Bone Marrow In Vivo Stem Cells, July 1, 2002; 20(4): 301 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Josephson, G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors PNAS, June 11, 2002; 99(12): 8295 - 8300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bertolini, C. Dell'Agnola, P. Mancuso, C. Rabascio, A. Burlini, S. Monestiroli, A. Gobbi, G. Pruneri, and G. Martinelli CXCR4 Neutralization, a Novel Therapeutic Approach for Non-Hodgkin's Lymphoma Cancer Res., June 1, 2002; 62(11): 3106 - 3112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen and D. E. Harrison Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood Blood, January 15, 2002; 99(2): 561 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Kim, J. Radford, M. Harris, J. Varley, A. J. Rutherford, B. Lieberman, S. Shalet, and R. Gosden Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation Hum. Reprod., October 1, 2001; 16(10): 2056 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. D. Rossi, K. L. Medina, K. Garrett, G. Kolar, P. C. Comp, L. D. Shultz, J. D. Capra, P. Wilson, A. Schipul, and P. W. Kincade Relatively Normal Human Lymphopoiesis but Rapid Turnover of Newly Formed B Cells in Transplanted Nonobese Diabetic/SCID Mice J. Immunol., September 15, 2001; 167(6): 3033 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Perez, H. M. Rinder, C. Wang, J. B. Tracey, N. Maun, and D. S. Krause Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production Blood, March 15, 2001; 97(6): 1635 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Saito-Ito, M. Tsuji, Q. Wei, S. He, T. Matsui, M. Kohsaki, S. Arai, T. Kamiyama, K. Hioki, and C. Ishihara Transfusion-Acquired, Autochthonous Human Babesiosis in Japan: Isolation of Babesia microti-Like Parasites with hu-RBC-SCID Mice J. Clin. Microbiol., December 1, 2000; 38(12): 4511 - 4516. [Abstract] [Full Text]
|
|
|
|
|
|
T. W. LeBien Fates of human B-cell precursors Blood, July 1, 2000; 96(1): 9 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bertolini, L. Fusetti, P. Mancuso, A. Gobbi, C. Corsini, P. F. Ferrucci, G. Martinelli, and G. Pruneri Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma Blood, July 1, 2000; 96(1): 282 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kollet, A. Peled, T. Byk, H. Ben-Hur, D. Greiner, L. Shultz, and T. Lapidot beta 2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function Blood, May 15, 2000; 95(10): 3102 - 3105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Shultz, P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al. NOD/LtSz-Rag1null Mice: An Immunodeficient and Radioresistant Model for Engraftment of Human Hematolymphoid Cells, HIV Infection, and Adoptive Transfer of NOD Mouse Diabetogenic T Cells J. Immunol., March 1, 2000; 164(5): 2496 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller, and S. Fruehauf Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice Blood, February 15, 2000; 95(4): 1237 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. An, R. P. Wersto, B. A. Agricola, M. E. Metzger, S. Lu, R. G. Amado, I. S. Y. Chen, and R. E. Donahue Marking and Gene Expression by a Lentivirus Vector in Transplanted Human and Nonhuman Primate CD34+ Cells J. Virol., February 1, 2000; 74(3): 1286 - 1295. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Novelli, M. Ramírez, W. Leung, and C. I. Civin Human Hematopoietic Stem/Progenitor Cells Generate CD5+ B Lymphoid Cells in NOD/SCID Mice Stem Cells, September 1, 1999; 17(5): 242 - 252. [Abstract] [Full Text]
|
|
|
|
|
|
A.-C. Fluckiger, E. Sanz, M. Garcia-Lloret, T. Su, Q.-L. Hao, R. Kato, S. Quan, A. de la Hera, G. M. Crooks, O. N. Witte, et al. In Vitro Reconstitution of Human B-Cell Ontogeny: From CD34+ Multipotent Progenitors to Ig-Secreting Cells Blood, December 15, 1998; 92(12): 4509 - 4520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. de Wynter, D. Buck, C. Hart, R. Heywood, L.H. Coutinho, A. Clayton, J.A. Rafferty, D. Burt, G. Guenechea, J. A. Bueren, et al. CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long-Term Culture-Initiating Cells, NOD/SCID-Repopulating Cells and Dendritic Cell Progenitors Stem Cells, November 1, 1998; 16(6): 387 - 396. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
